These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gallbladder emptying determines early gallstone clearance after shock-wave lithotripsy. Pauletzki J; Sailer C; Klüppelberg U; von Ritter C; Neubrand M; Holl J; Sauerbruch T; Sackmann M; Paumgartner G Gastroenterology; 1994 Nov; 107(5):1496-502. PubMed ID: 7926513 [TBL] [Abstract][Full Text] [Related]
3. Gallbladder motility before and after extracorporeal shock-wave lithotripsy. Spengler U; Sackmann M; Sauerbruch T; Holl J; Paumgartner G Gastroenterology; 1989 Mar; 96(3):860-3. PubMed ID: 2914646 [TBL] [Abstract][Full Text] [Related]
4. Erythromycin, a motilin agonist, increases postprandial gallbladder emptying during therapy with ursodeoxycholic acid. Neubrand M; Sauerbruch T Z Gastroenterol; 1998 Apr; 36(4):267-71. PubMed ID: 9612923 [TBL] [Abstract][Full Text] [Related]
5. Increased gallbladder residual volume in nonresponders to extracorporeal shock wave lithotripsy of gallbladder stones. Janowitz P; Wechsler JG; Kuhn K; Kratzer W; Tudyka J; Maier C; Ditschuneit H Am J Gastroenterol; 1992 Oct; 87(10):1429-32. PubMed ID: 1415099 [TBL] [Abstract][Full Text] [Related]
6. Tauroursodeoxycholic acid, ursodeoxycholic acid and gallbladder motility in gallstone patients and healthy subjects. Portincasa P; DiCiaula A; Palmieri V; Velardi A; Van Berge-Henegouwen GP; Palasciano G Ital J Gastroenterol; 1996; 28(2):111-3. PubMed ID: 8782006 [TBL] [Abstract][Full Text] [Related]
7. Gallbladder emptying is an important factor in fragment disappearance after shock wave lithotripsy. Sackmann M; Eder H; Spengler U; Pauletzki J; Holl J; Paumgartner G; Sauerbruch T J Hepatol; 1993 Jan; 17(1):62-6. PubMed ID: 8445221 [TBL] [Abstract][Full Text] [Related]
8. Effect of extracorporeal shock-wave lithotripsy on gallbladder emptying in patients with solitary and multiple gallbladder stones. Kratzer W; Mason RA; Haag U; Maier C; Janowitz P; Beckh K; Adler G Dig Dis Sci; 1995 Jun; 40(6):1179-84. PubMed ID: 7781431 [TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholic acid for adjuvant therapy with extracorporeal shock wave lithotripsy of gallstones. Fromm H J Clin Gastroenterol; 1988; 10 Suppl 2():S18-21. PubMed ID: 3062080 [TBL] [Abstract][Full Text] [Related]
13. [Optimized extracorporeal shockwave lithotripsy of gallbladder calculi: a prospective randomized therapy comparison]. Rabenstein T; Benninger J; Farnbacher M; May A; Ell C; Katalinic A; Hahn EG; Schneider HT Z Gastroenterol; 1999 Mar; 37(3):209-17. PubMed ID: 10234793 [TBL] [Abstract][Full Text] [Related]
14. Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution. Festi D; Frabboni R; Bazzoli F; Sangermano A; Ronchi M; Rossi L; Parini P; Orsini M; Primerano AM; Mazzella G Gastroenterology; 1990 Dec; 99(6):1779-85. PubMed ID: 2227291 [TBL] [Abstract][Full Text] [Related]
15. Extracorporeal shock wave lithotripsy of gallstones with oral dissolution. Results in course of ten years in Czech Republic in correlation to indication criteria. Benes J; Chmel J; Blazek O; Marecek Z Sb Lek; 2001; 102(1):17-22. PubMed ID: 11830914 [TBL] [Abstract][Full Text] [Related]
16. Early results of combined electrohydraulic shock-wave lithotripsy and oral litholytic therapy of gallbladder stones at the University of Iowa. Maher JW; Summers RW; Dean TR; Swift J; Heitshusen D; Quinn G Surgery; 1990 Oct; 108(4):648-52; discussion 653-4. PubMed ID: 2218875 [TBL] [Abstract][Full Text] [Related]
17. [Oral dissolvents and extracorporeal lithotripsy: respective role and modalities of application]. Erlinger S Rev Prat; 1992 Jun; 42(12):1487-9. PubMed ID: 1411171 [TBL] [Abstract][Full Text] [Related]
18. Absence of apolipoprotein E4 genotype, good gallbladder motility and presence of solitary stones delay rather than prevent gallstone recurrence after extracorporeal shock wave lithotripsy. Venneman NG; vanBerge-Henegouwen GP; Portincasa P; Stolk MF; Vos A; Plaisier PW; van Erpecum KJ J Hepatol; 2001 Jul; 35(1):10-6. PubMed ID: 11495026 [TBL] [Abstract][Full Text] [Related]